{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:04:45Z","timestamp":1789941885657,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.joms.2009.10.010","type":"journal-article","created":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T06:53:18Z","timestamp":1265871198000},"page":"959-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":224,"title":["Osteonecrosis of the Jaw in a Patient on Denosumab"],"prefix":"10.1016","volume":"68","author":[{"given":"Tara L.","family":"Aghaloo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Felsenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2009.10.010_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: Bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joms.2009.10.010_bib2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1359\/jbmr.060712","article-title":"Osteonecrosis of the jaw: More research needed","volume":"21","author":"Shane","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2009.10.010_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.critrevonc.2006.12.005","article-title":"Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients\u2014May 2006","volume":"62","author":"Weitzman","year":"2007","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.joms.2009.10.010_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.joen.2008.11.002","article-title":"Osteonecrosis related to intraosseous anesthesia: Report of a case","volume":"35","author":"Woodmansey","year":"2009","journal-title":"J Endod"},{"key":"10.1016\/j.joms.2009.10.010_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tripleo.2005.06.022","article-title":"Mandibular osteomyelitis and tooth exfoliation following zoster-CMV co-infection","volume":"101","author":"Meer","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2009.10.010_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/joms.2003.50095","article-title":"A case of maxillary necrosis","volume":"61","author":"Pogrel","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1834-7819.2003.tb00011.x","article-title":"Oral ulceration with bone sequestration","volume":"48","author":"Farah","year":"2003","journal-title":"Aust Dent J"},{"key":"10.1016\/j.joms.2009.10.010_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1079-2104(98)90400-0","article-title":"A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws","volume":"85","author":"Glueck","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2009.10.010_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hed.2890040313","article-title":"Osteonecrosis of the jaws: A complication of cancer chemotherapy","volume":"4","author":"Schwartz","year":"1982","journal-title":"Head Neck Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib11","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.joms.2003.09.001","article-title":"Avascular necrosis of the jaws: Risk factors in metastatic cancer patients","volume":"61","author":"Tarassoff","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2009.10.010_bib13","article-title":"Package insert revisions re: Osteonecrosis of the jaws: Zometa injection and Aredia injection","author":"Odac","year":"2005","journal-title":"Package insert"},{"key":"10.1016\/j.joms.2009.10.010_bib14","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2009.10.010_bib15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib17","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphanates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2009.10.010_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.mlg.0000240885.64568.9e","article-title":"Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review","volume":"117","author":"Mortensen","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.joms.2009.10.010_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: A single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.joms.2009.10.010_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: Series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.joms.2009.10.010_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.otohns.2006.11.008","article-title":"Bisphosphonates and jaw osteonecrosis: The UAMS experience","volume":"136","author":"Clarke","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2009.10.010_bib23","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.joms.2009.10.010_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/10428190600977690","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: A review of 35 cases and an evaluation of its frequency in multiple myeloma patients","volume":"48","author":"Pozzi","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.joms.2009.10.010_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.joms.2009.10.010_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib27","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.joms.2009.10.010_bib28","article-title":"Bisphosphonate complications including osteonecrosis of the jaw","volume":"356","author":"Mehrotra","year":"2006","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.joms.2009.10.010_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management","volume":"102","author":"Ruggiero","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2009.10.010_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/CIA.S3333","article-title":"Emerging treatments for postmenopausal osteoporosis\u2014Focus on Denosumab","volume":"4","author":"Geusens","year":"2009","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.joms.2009.10.010_bib31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/BOR.0b013e32832ca41c","article-title":"Denosumab update","volume":"21","author":"Lewiecki","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.joms.2009.10.010_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/CCO.0b013e32832c951d","article-title":"Giant cell tumour of bone","volume":"21","author":"Thomas","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.joms.2009.10.010_bib33","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized phase II trial of Denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates","volume":"27","author":"Fizazi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2009.10.010_bib34","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 Update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.10.010_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.joms.2009.10.010_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","article-title":"Osteoclasts: What do they do and how do they do it?","volume":"170","author":"Teitelbaum","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joms.2009.10.010_bib37","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00018-007-7104-0","article-title":"RANKL, RANK, osteoprotegerin: Key partners of osteoimmunology and vascular diseases","volume":"64","author":"Baud'Huin","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.joms.2009.10.010_bib38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bone.2006.03.016","article-title":"OPG\/membranous\u2014RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation","volume":"39","author":"Tat","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.joms.2009.10.010_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.joms.2009.10.010_bib40","series-title":"Pathology and Genetics of Tumours of Soft Tissue and Bone","year":"2002"},{"key":"10.1016\/j.joms.2009.10.010_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9440(10)62959-8","article-title":"Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB","volume":"167","author":"Morgan","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joms.2009.10.010_bib42","first-page":"643","article-title":"A new bisphosphonate treatment option for giant cell tumors","volume":"8","author":"Fujimoto","year":"2001","journal-title":"Oncol Rep"},{"key":"10.1016\/j.joms.2009.10.010_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2007.08.038","article-title":"Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: A case-control study","volume":"42","author":"Tse","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.joms.2009.10.010_bib44","doi-asserted-by":"crossref","first-page":"10500","DOI":"10.1200\/jco.2008.26.15_suppl.10500","article-title":"Denosumab treatment of giant cell tumor of bone: Interim analysis of an open-label phase II study","volume":"26","author":"Thomas","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2009.10.010_bib45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.1997.2713086.x","article-title":"Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumour activity","volume":"98","author":"Shipman","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.joms.2009.10.010_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(95)00150-6","article-title":"A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders","volume":"17","author":"Murakami","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.joms.2009.10.010_bib47","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2009.10.010_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jbmr.5650050107","article-title":"Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy","volume":"5","author":"Sato","year":"1990","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2009.10.010_bib49","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2009.10.010_bib50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00223-004-0024-1","article-title":"From molds and macrophages to mevalonate: A decade of progress in understanding the molecular mode of action of bisphosphonates","volume":"75","author":"Rogers","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.joms.2009.10.010_bib51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2009.10.010_bib52","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","article-title":"Protein geranylgeranylation is required for osteoclast formation, function, and survival: Inhibition by bisphosphonates and GGTI-298","volume":"15","author":"Coxon","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2009.10.010_bib53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0955-0674(93)90130-I","article-title":"Rab GTPases in vesicular transport","volume":"5","author":"Zerial","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.joms.2009.10.010_bib54","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.joms.2009.10.010_bib55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02547227","article-title":"The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals","volume":"11","author":"Jung","year":"1973","journal-title":"Calcif Tissue Res"},{"key":"10.1016\/j.joms.2009.10.010_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3816\/SCT.2006.n.026","article-title":"Novel approaches in the management of myeloma-related skeletal complications","volume":"4","author":"Reddy","year":"2006","journal-title":"Support Cancer Ther"},{"key":"10.1016\/j.joms.2009.10.010_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1445-5994.2008.01732.x","article-title":"Clinical applications of RANK-ligand inhibition","volume":"39","author":"Romas","year":"2009","journal-title":"Int Med J"},{"key":"10.1016\/j.joms.2009.10.010_bib58","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2009.10.010_bib59","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2009.10.010_bib60","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1078-0432.CCR-05-1933","article-title":"A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, Denosumab, in patients with multiple myeloma or bone metastases from breast cancer","volume":"12","author":"Body","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2009.10.010_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of Denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: A randomized, blinded, phase 3 trial","volume":"24","author":"Brown","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2009.10.010_bib62","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2007.11.8604","article-title":"Randomized active-controlled phase II study of Denosumab efficacy and safety in patients with breast cancer-related bone metastases","volume":"25","author":"Lipton","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2009.10.010_bib63","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1158\/1078-0432.CCR-07-5234","article-title":"Extended efficacy and safety of Denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy","volume":"14","author":"Lipton","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2009.10.010_bib64","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239109019405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239109019405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:33:13Z","timestamp":1759509193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239109019405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0278239109019405"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2009.10.010","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteonecrosis of the Jaw in a Patient on Denosumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2009.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}